Global Everolimus eprocurement Notices and Bids

Supply of Everolimus 0.75 Mg Tablets, Everolimus 10 Mg Tablets, Everolimus 2 Mg Tablets

Supply of Everolimus 2.5mg Tablets, Everolimus 3 Mg Tablets, Everolimus 5 Mg Tablets

Supply of Everolimus 0.25 Mg Orodispersible Tablets, Everolimus 0.25 Mg Sublingual Tablets

Medicines with the Active Ingredient Everolimus (Atc: L04aa18)

Open House Drug Rebate Agreements Everolimus, Atc L04aa18 and Everolimus as Off-Patent Oncology

Supply of Etravirine 100mg Tablets, Etravirine 200mg Tablets, Everolimus 0.25 Mg Tablets

Open House Discount Agreements 2024-03 - Everolimus (Atc: L04ah02; Tab)

Open-house Model to the Active Ingredient Everolimus (atc L01eg02)

of a So-Called Open House Model for the Active Ingredient Everolimus (Atc L01eg02)

V for the Active Ingredient Everolimus, Atc L04aa18 for the Period February 1St, 2024 - January 31St, 2...